Therapeutic Apheresis And Dialysis

Therapeutic Apheresis And Dialysis

治疗性单采和透析

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Therapeutic Apheresis And Dialysis》是由Wiley-Blackwell Publishing Ltd出版社于2003年创办的英文国际期刊(ISSN: 1744-9979,E-ISSN: 1744-9987),该期刊长期致力于血液学领域的创新研究,主要研究方向为医学-泌尿学与肾脏学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.2215...%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比90.72%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在97篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Therapeutic Apheresis And Dialysis审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约97篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 97 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
HEMATOLOGY 血液学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
HEMATOLOGY 血液学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q3 70 / 97

28.4%

学科:UROLOGY & NEPHROLOGY SCIE Q3 78 / 126

38.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q3 62 / 97

36.6%

学科:UROLOGY & NEPHROLOGY SCIE Q3 87 / 126

31.35%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3 SJR:0.419 SNIP:0.627
学科类别 分区 排名 百分位
大类:Medicine 小类:Nephrology Q3 44 / 81

46%

大类:Medicine 小类:Hematology Q3 79 / 137

42%

期刊发文

  • Efficacy and safety of plasma diafiltration: Review of case reports and case series

    Author: Zhang, Yannan; Dong, Rui; Li, Ying; Yang, Xin; Liu, Jiang; Ou, Santao; Wu, Weihua

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 1, pp. 3-11. DOI: 10.1111/1744-9987.13859

  • Patients with end-stage renal disease and diabetes had similar survival rates whether they received hemodialysis or peritoneal dialysis

    Author: Xu, Feng; Yang, Yue; Wu, Man; Zhou, Wenhua; Wang, Dongxue; Cui, Wenpeng

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 1, pp. 59-65. DOI: 10.1111/1744-9987.13890

  • The significance of follow-up serum uric acid levels in predicting all-cause mortality and cardiovascular mortality in peritoneal dialysis patients

    Author: Wang, Yaomin; Zhang, Qilong; Ren, Pingping; Pan, Yixuan; Liu, Yi; Li, Chenglin; Fan, Zhenzhen; Han, Fei; Zhang, Xiaohui; Chen, Jianghua

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 1, pp. 83-90. DOI: 10.1111/1744-9987.13892

  • Safety of a 24-h-or-less break-in period in elderly patients undergoing urgent-start peritoneal dialysis: A multicenter retrospective cohort study

    Author: Cheng, Siyu; Yang, Liming; Sun, Zhanshan; Zhang, Xiaoxuan; Zhu, Xueyan; Meng, Lingfei; Guo, Shizheng; Zhuang, Xiaohua; Luo, Ping; Cui, Wenpeng

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 2, pp. 304-313. DOI: 10.1111/1744-9987.13907

  • A dynamic nomogram for predicting survival among diabetic patients on maintenance hemodialysis

    Author: Chen, Ying; Wang, Yao; Shen, Yan; Dai, Houyong; Huang, Xinzhong; Fang, Li; Huang, Xi; Shen, Yi; Yuan, Li

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 1, pp. 39-49. DOI: 10.1111/1744-9987.13901

  • miR-128-3p inhibits high-glucose-induced peritoneal mesothelial cells fibrosis via PAK2/SyK/TGF-beta 1 axis

    Author: Zhang, Yao; Xiao, Wu-Hao; Huang, Yi-Xiong; Yang, Yi-Ya; Ouyang, Sha-Xi; Liang, Yu-Mei; Liu, Kang-Han

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 2, pp. 343-352. DOI: 10.1111/1744-9987.13912

  • Timing of initiation of renal replacement therapy for patients with acute kidney injury: A meta-analysis of RCTs

    Author: Li, Yunjie; Zhang, Yong; Li, Rui; Zhang, Ming; Gao, Xiang

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 2, pp. 207-221. DOI: 10.1111/1744-9987.13914

  • Treatment for cephalic arch stenosis with cephalic vein to external jugular vein bridging graft

    Author: Xia, Lianghong; Chen, Jianguo; Ye, Youxin

    Journal: THERAPEUTIC APHERESIS AND DIALYSIS. 2023; Vol. 27, Issue 2, pp. 293-295. DOI: 10.1111/1744-9987.13923